4/A

FORM 4/A SUBMISSION

Company: Lineage Cell Therapeutics, Inc.
Filed: March 23, 2005
Period of Report: March 21, 2005
Accession Number: 0001209191-05-017302

View Document ↗ View on SEC.gov ↗